#153329

HR1 Cell Line

Please Enter Your Email ID
Email ID

Cat. #153329

HR1 Cell Line

Cat. #: 153329

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

Organism: Human

Tissue: Kidney

Disease: Cancer

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Simon Cook

Institute: Babraham Institute

Tool Details
Target Details
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: HR1 Cell Line
  • Alternate name: RAF proto-oncogene serine/threonine-protein kinase (EC:2.7.11.1), Proto-oncogene c-RAF, cRaf, Raf-1
  • Research fields: Apoptosis and autophagy;Cancer;Cell biology;Cell signaling and signal transduction;Immunology
  • Tool sub type: Continuous
  • Parental cell: HEK 293
  • Organism: Human
  • Tissue: Kidney
  • Disease: Cancer
  • Growth properties: Adherent cell line
  • Conditional: Yes
  • Conditional description: Stable transfectant, conditional functionality: c-Raf1 kinase activity and ERK1/2 signalling pathway activated following 4-hydroxytamoxifen (4-HT) treatment of cells.
  • Description: HR1 cells are HEK 293 cells stably expressing conditional kinase ∆Raf-1:ER* from the pCMV Neo Myc plasmid. ∆Raf-1:ER* (also known as ∆CRAF:ER*) consists of the isolated kinase domain of c-Raf1 fused in-frame to a modified form of the hormone binding domain of the estrogen receptor (hbER*) that can be de-repressed by 4-hydroxytamoxifen (4-HT) but not β-estradiol. In this case the * refers to a point mutation that ablates estradiol binding but allows 4-HT binding. Activation of ∆Raf-1:ER* leads to the selective activation of the ERK1/2 pathway. This cell line can be used to study the cellular role and factors impacting on the ERK1/2 signalling pathway such as gene expression, cell proliferation, cell cycle arrest and cell death. The cells are G418 resistant. Conditional kinase activation of ∆Raf-1:ER* can be induced with 100nM 4-HT.
  • Production details: HEK 293 cells were transfected with the pCMV Neo Myc plasmid expressing â?‚ˆ?‚†Raf-1:ER*. Stable transfectants were selected by neomycin resistance using G418 (Geneticin) and ring cloning.
  • Cellosaurus id: CVCL_2676

Target Details

  • Target: c-Raf1

Handling

  • Format: Frozen
  • Growth medium: Phenol red-free Dulbecco's modified Eagle's medium (DMEM) high glucose version, 2 mM L-glutamine, 10% fetal bovine serum (FBS), 400 ?g/ml G418 (Geneticin).
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

Related Tools

  • Related tools: HM3 Cell Line

References

  • Gilley et al. 2009. Cell Signal. 21(6):969-77. PMID: 19249353.
  • ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos.
  • Wiggins et al. 2007. Cell Signal. 19(12):2605-11. PMID: 17884340.
  • c-Cbl is not required for ERK1/2-dependent degradation of BimEL.
  • Ewings et al. 2007. EMBO J. 26(12):2856-67. PMID: 17525735.
  • ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL.
  • Boughan et al. 2006. J Biol Chem. 281(1...